Find Naloxegol Oxalate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

KDMF

KDMF

0

VMF

NDC API

API REF. PRICE (USD/KG)

MARKET PLACE

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF DossiersDRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Exclusivities

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

150 RELATED EXCIPIENT COMPANIES

258EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 1354744-91-4, Nktr-118 oxalate, Naloxegol (oxalate), Naloxegol oxalate [usan], Az13337019 oxalate, Az-13337019 oxalate
Molecular Formula
C36H55NO15
Molecular Weight
741.8  g/mol
InChI Key
MNYIRXLCPODKLG-VUTNLTPYSA-N
FDA UNII
65I14TNM33

Naloxegol Oxalate
1 2D Structure

Naloxegol Oxalate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(4R,4aS,7S,7aR,12bS)-7-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]-3-prop-2-enyl-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol;oxalic acid
2.1.2 InChI
InChI=1S/C34H53NO11.C2H2O4/c1-3-9-35-10-8-33-30-26-4-5-27(36)31(30)46-32(33)28(6-7-34(33,37)29(35)25-26)45-24-23-44-22-21-43-20-19-42-18-17-41-16-15-40-14-13-39-12-11-38-2;3-1(4)2(5)6/h3-5,28-29,32,36-37H,1,6-25H2,2H3;(H,3,4)(H,5,6)/t28-,29+,32-,33-,34+;/m0./s1
2.1.3 InChI Key
MNYIRXLCPODKLG-VUTNLTPYSA-N
2.1.4 Canonical SMILES
COCCOCCOCCOCCOCCOCCOCCOC1CCC2(C3CC4=C5C2(C1OC5=C(C=C4)O)CCN3CC=C)O.C(=O)(C(=O)O)O
2.1.5 Isomeric SMILES
COCCOCCOCCOCCOCCOCCOCCO[C@H]1CC[C@]2([C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)O)CCN3CC=C)O.C(=O)(C(=O)O)O
2.2 Other Identifiers
2.2.1 UNII
65I14TNM33
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 1354744-91-4

2. Nktr-118 Oxalate

3. Naloxegol (oxalate)

4. Naloxegol Oxalate [usan]

5. Az13337019 Oxalate

6. Az-13337019 Oxalate

7. 65i14tnm33

8. Moventig

9. (4r,4as,7s,7ar,12bs)-7-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]-3-prop-2-enyl-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol;oxalic Acid

10. Naloxegol Oxalate (usan)

11. Unii-65i14tnm33

12. Movantik (tn)

13. Moventig (tn)

14. Nktr-118-oxalate

15. Naloxegol Oxalate [mi]

16. Naloxegol Oxalate(nktr-118)

17. Chembl2219416

18. Schembl20839999

19. Hy-a0118a

20. Dtxsid50159395

21. Naloxegol Oxalate [who-dd]

22. Akos030526444

23. Cs-5349

24. Naloxegol Oxalate [orange Book]

25. Nktr-118;az-13337019 Oxalate

26. Ac-36031

27. Movantik Component Naloxegol Oxalate

28. Az 13337019

29. Naloxegol Oxalate Component Of Movantik

30. D10375

31. Q27263878

32. 4,5.alpha.-epoxy-6.alpha.-((3,6,7,12,15,18,21-heptaoxadocosyl)oxy)-17-(prop-2-enyl)morphinan-3,14-diol Hydrogen Ethanedioate

33. 4,5alpha-epoxy-6alpha-((3,6,7,12,15,18,21-heptaoxadocosyl)oxy)-17-(prop-2-enyl)morphinan-3,14-diol Hydrogen Ethanedioate

34. Morphinan-3,14-diol, 4,5-epoxy-6-(3,6,9,12,15,18,21-heptaoxadocos-1-yloxy)-17-(2-propen-1-yl)-, (5.alpha.,6.alpha.)-, Ethanedioate (1:1)

35. Morphinan-3,14-diol, 4,5-epoxy-6-(3,6,9,12,15,18,21-heptaoxadocos-1-yloxy)-17-(2-propen-1-yl)-, (5alpha,6alpha)-, Ethanedioate (1:1)

2.4 Create Date
2012-05-14
3 Chemical and Physical Properties
Molecular Weight 741.8 g/mol
Molecular Formula C36H55NO15
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count16
Rotatable Bond Count25
Exact Mass741.35717005 g/mol
Monoisotopic Mass741.35717005 g/mol
Topological Polar Surface Area201 Ų
Heavy Atom Count52
Formal Charge0
Complexity971
Isotope Atom Count0
Defined Atom Stereocenter Count5
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Indication

Treatment of opioid-induced constipation (OIC) in adult patients who have had an inadequate response to laxative(s).


5 Pharmacology and Biochemistry
5.1 FDA Pharmacological Classification
5.1.1 Pharmacological Classes
Opioid Antagonists [MoA]; Opioid Antagonist [EPC]
5.2 ATC Code

A06AH03


API SUPPLIERS

read-more
read-more
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1663785000,"product":"MSN LIFE, NALOXEGOL OXALATE (AS PER INVO","address":"MSN HOUSE,PLOT NO.C-24,INDUSTRIAL E SANATH NAGAR,HYDERABAD","city":"HYDERABAD TS","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"TORONTO","customer":"TO THE ORDER OF.,","customerCountry":"CANADA","quantity":"3.00","actualQuantity":"3","unit":"KGS","unitRateFc":"50000","totalValueFC":"146841.1","currency":"USD","unitRateINR":3922666.6666666665,"date":"22-Sep-2022","totalValueINR":"11768000","totalValueInUsd":"146841.1","indian_port":"HYDERABAD AIR","hs_no":"29391900","bill_no":"4348084","productDescription":"API","marketType":"REGULATED MARKET","country":"CANADA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"MSN HOUSE,PLOT NO.C-24,INDUSTRIAL E SANATH NAGAR,HYDERABAD, HYDERABAD TS","customerAddress":""}]
22-Sep-2022
22-Sep-2022
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - TABLET;ORAL - EQ 12.5MG BASE

USFDA APPLICATION NUMBER - 204760

read-more

DOSAGE - TABLET;ORAL - EQ 25MG BASE

USFDA APPLICATION NUMBER - 204760

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Coating Systems & Additives

read-more
read-more

Fillers, Diluents & Binders

read-more
read-more

Direct Compression

read-more
read-more

Controlled & Modified Release

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Co-Processed Excipients

read-more
read-more

Granulation

read-more
read-more

Taste Masking

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Lubricants & Glidants

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

API Stability Enhancers

read-more
read-more

Empty Capsules

read-more
read-more

Coloring Agents

read-more
read-more

Parenteral

read-more
read-more

Vegetarian Capsules

read-more
read-more

Rheology Modifiers

read-more
read-more

Emulsifying Agents

read-more
read-more

Topical

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Solubilizers

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty